The coming medical care burden differs substantially across countries. The countries that will be hardest hit by demographic change are Spain, Switzerland, the Czech Republic, Italy, and Greece. All of these countries have very low fertility rates and large projected increases in life expectancy. Demographic change will raise medical spending in these countries by 5 to 6 percent of GDP. Japan and the United States rank in the middle on this scale, 9 th and 12 th respectively out of 29 countries (expected increases of 4.4 and 3.7 percent). The least affected countries include Turkey, the United Kingdom, New Zealand, and Mexico, with an expected increase of 2 percent or less.
Accounting for technological change has a material impact on these rankings.
Most importantly, it raises the financing burden in the United States. The US spends more than other countries do on medical care, and has the most technologically advanced medical system. Thus, if technology increases costs at the same rate everywhere, the United States will be particularly hard hit. Using historical growth rates of medical costs as a guide to the future, the projected increase in medical spending in the US over the next 30 years is close to 10 percent. The increase in Japan will be over 6 percent of GDP.
These are sizeable estimates, although perhaps not cataclysmic. I show that affording such increases will require reductions in the growth of non-medical consumption, but not absolute declines in the level of such spending.
This paper is structured as follows. The first section lays out the nature of the medical care problem and the structure of the simulation model. The second section describes the consequences of demographic change alone. The third section then adds in technological change in medical treatments. The fourth section discusses the implications for the affordability of medical care overall, and the last section concludes.
I. Forecasting Medical Care Spending
The need to forecast medical spending is obvious. Medical care is 10 percent of GDP or more in most developed countries, and is growing rapidly. Most of this medical care is paid for by the public sector (over 80 percent in most countries). Thus, public concern about rising costs is particularly high. But medical costs are a concern in the private sector as well. Increased medical spending involves painful adjustments as families shift their spending allocations among different goods and businesses pass on the costs of medical care to workers. None of this implies that medical spending increases are bad, but it indicates why we need to know what the medical burden will be.
Forecasting medical spending is simple in some ways and horribly complex in others. To understand the issues, I start with a truism: medical spending as a share of GDP is the division of per capita medical spending by per capita output. To forecast the share of GDP devoted to medical care, therefore, I forecast these two terms.
Start with medical spending. Per capita medical spending is the product of the number of people at each age times spending at that age, divided by the number of people in the country as a whole. Denoting age groups with the subscript a, this can be expressed as:
(1) Per capita medical spending = ∑ a Pop a * Spend a / Total Pop To forecast medical spending, therefore, we need projections of the population and spending at each age.
The United Nations publishes projections of population by age (United Nations
Population Division, 1998 I further assume that relative spending will remain the same at different ages in the future. In the United States, spending on the aged has increased more rapidly than spending on the non-aged, as technological change has tilted towards the elderly (Cutler and Meara, 1998; . In the absence of better information, however, there is little ability to forecast continued changes in this ratio.
The second assumption is about the impact of medical technology on costs. As the capabilities of medicine expand, what will happen to overall medical spending? It is clear that increases in the technical sophistication of medicine have been a fundamental factor in rising medical costs in the past, far surpassing the roles of increased income, more generous insurance, and an older population on medical costs (Newhouse, 1992; Medicare Technical Advisory Panel, 2000) . The reason is clear -medical technology moved diseases from untreatable to treatable. For example, coronary bypass surgery replaced watchful waiting as a primary therapy for people with a heart attack in the 1980s and 1990s. Monitoring without intervention is cheap; bypass surgery is expensive.
Hence, developing bypass surgery led to increased medical spending.
There is no indication that technological change is becoming less rapid. If anything, it is speeding up with the genomic revolution and advances in traditional therapies such as surgeries and diagnostic equipment (JAMA, 2001) . Thus, one might expect that medical spending will continue to increase.
But the translation between technological change and spending is more complex.
Where lack of treatment was once the norm, today most conditions are treated in some fashion. As a result, in the future, new treatments will increasingly substitute for older ones. If the newer procedures are cheaper than the older procedures they replace, the use of new procedures may not lead to as rapid cost increase. To follow the heart attack example, angioplasty recently joined bypass surgery as a recognized therapy for heart attacks. Some angioplasties substitute for bypass surgery. Since angioplasty is cheaper than bypass surgery, the use of this technology saves money in some cases (Cutler and Huckman, 2003) .
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The ultimate impact of technological change on medical spending depends on the relative importance of these 'treatment expansion' and 'treatment substitution' effects. It will not necessarily be the case that medical spending continues to rise as medicine becomes more technologically sophisticated.
Most forecasts suggest that technological change will increase to increase spending, however. A consensus estimate is that medical spending will increase 1 percent more rapidly than GDP in the next few decades (Medicare Technical Advisory Panel, 2000) . I use this estimate in my simulations.
Translating this estimate internationally requires additional assumptions. Medical spending is lower in other countries than in the United States. If medical costs increase 1 percent more rapidly than GDP everywhere, the dollar increase will be smaller abroad than in the US. Thus, there will be a growing divergence between medical costs in different countries. Is this possible? In principle, yes. Even though medical technology has expanded in all countries over the past half century, the increase has been far larger in the US than elsewhere, as Figure 1 shows. The US has thus become even more of an outlier than it was already. For lack of a better alternative, I assume this will continue in the future. One issue for future exploration is the implications of assuming some convergence in spending.
In addition to forecasting medical spending, we need to forecast per capita income. We can express per capita income using a formula similar to equation (1): (2) Per capita income = ∑ a Workers a * Output a / Total Pop A complete projection of equation (2) would forecast the number of workers at each age along with output of those workers. No projections that detailed are available. I thus make simpler assumptions. I assume that labor force participation is confined to the 15-64 year-old population, and that labor force participation in that group remains constant. Further, I assume that output for all workers rises at the same rate. For these simulations, the rate of increase is immaterial; the key is the differential between health care cost growth and output growth. As discussed above, I assume this differential is 1 percent.
Effectively, these assumptions mean that changes in output are driven entirely by changes in share of the population that is working age. As a first pass simulation model, this does not seem unreasonable.
II. Demographics and Medical Spending
To understand the medical care problem, I start with some basic demographic information across countries. The share of the population that is elderly varies greatly across the developed world. Figure 2 shows this variation. Thirteen percent of the OECD as a whole is over the age of 65. Italy has the largest elderly share, at 18 percent, with Greece, Sweden, Japan, and Spain also being very high. For all of the worries about aging in the United States, the United States population is not very elderly (by developed country standards); 12 percent of the US population is over age 65.
The major driver of aging is fertility. Most countries have fertility rates that are below replacement levels (about 2.1 births per woman). Italy, for example, has a birth rate of 1.2 babies per woman, and Japan is 1.4. Birth rates this low inevitably imply an aging population. Added to the low fertility rate are increases in longevity at older ages.
In the United States, the average 45 year-old lives nearly five years longer now than in 1950. Finally, immigration rates are low in most OECD countries. Immigration from poor to rich countries does not change the world's share of elderly people, but it does change the share in any particular country. A county with low net immigration will be increasingly older.
The net impact of these demographic changes is a projection of substantial increases in the elderly population over time. Figure 3 shows the forecast increase in the elderly share between 2000 and 2050. The expected increase is large in all countries.
The highest rates of increase are forecast in Spain, the Czech Republic, Korea, and Italy.
These countries will see increases in the elderly population of over 15 percentage points if nothing else intervenes. The average OECD country will experience an increase of 11 percentage points, and even countries at the very low end (the United Kingdom and the United States, for example) will have increases of 9 percentage points.
One sunny side of aging is fewer children, and thus more workers among the nonelderly population (Cutler, Poterba, Sheiner, and Summers, 1990 ). This is not enough to overwhelm the effect of increased elderly shares on medical spending, however. To examine the effect of demographic changes on the medical system, I simulate spending assuming no change in per person medical care utilization in the next half century. While this is obviously unrealistic, it provides a benchmark to assess the importance of demographic changes.
The results of the simulation are shown in Figure 4 . Note the mean first. In the average OECD country, demographic change alone will increase medical spending as a share of GDP by 3.6 percentage points in the next half century. This is a large increase, but perhaps not insurmountable. Most of this increase is in the next 30 years, where the increase will average 2.2 percentage points. The retirement of the baby boom generation will lead the procession into an era of more rapidly rising medical costs.
The ranking of countries is similar in Figure 4 as in Figure 3 , but the two are not exactly the same. The countries with the biggest increase are Spain, Switzerland, the Czech Republic, Italy, and Greece. All of these countries will have medical spending increases of over 5 percent of GDP, based on demographic change alone. The United
States is higher ranked in Figure 4 than in Figure 3 . Because medical spending in the US is so high, the same amount of demographic change has a larger impact on per capita spending than it does elsewhere. The forecast increase in the US is 3.7 percentage points.
In Japan, the forecast increase is 4.4 percentage points.
At the bottom of the list are Turkey and the United Kingdom. The comparatively low rate of aging in the UK combined with a low level of medical spending blunts the impact of demographic change on medical costs. But even in the UK, demographic change will lead to a 2 percent increase in the share of medical care in GDP. It is clear that demographic change will present a financing hurdle for all developed countries.
III. Including Technological Change
A more complete simulation includes the effects of technological change as well as population aging. As noted above, I assume that medical costs increase at all ages by 1 percent per year above the rate of per capita GDP growth. Forecast out forever, this is clearly unrealistic; it implies that medical care would ultimately account for all of GDP.
Thus, some limit on the time period for forecasting is needed.
To illustrate the importance of technical change, I consider a more limited simulation of medical spending in the next 30 years, to 2030. A steady increase in costs over the next three decades is (perhaps) more realistic than assuming the same increase over the next 50 years. Figure 5 shows the resulting estimates of the change in medical spending relative to GDP. Even in the next 30 years, the simulation implies large increases in medical spending. In the average OECD country, the increase in GDP share is 5.7 percentage points. That is greater than the 2.2 percentage points attributable to demographic change in this time period, although the additional part due to technical change (3.5 percentage points) is not much larger than the demographic component.
Most notable in Figure 5 are the enormously high increases projected in Switzerland and the United States. Medical spending in each of those countries is projected to increase by over 9 percent, to levels of about 25 percent of GDP. The medical cost problem is more severe in these countries because medical spending in those countries is so high. Hence, continued increases in costs result in disproportionately large increases in the medical sector. In Japan, the increase in the medical care burden is between 6 and 7 percent.
IV. Is Such Spending Sustainable?
The increase in medical spending will have several implications for the economy.
The first issue is whether such cost increases are good or harmful. Would society be harmed by spending so much on medical care? Clearly, people can have different views about this. My belief is that increases in spending of this magnitude are affordable. Recall that economic growth is forecast to be relatively robust over the next half century. Hence, the size of the economic pie is expanding. The increase in medical care relative to GDP implies that the medical care slice of the pie is getting bigger. But the medical slice is not growing more rapidly than the pie itself. Even in these simulations, non-medical consumption is still increasing over time. The statement that we can afford to spend more on medical care does not mean that we should do so. Most Americans could afford a large screen TV, but not everyone chooses to do so. Other goods and services are important as well. We thus need to evaluate whether money spent on medical care is worth the expense.
This question cannot be answered using the simulations here. These simulations show what we will pay for medical advance, but not what we will get for it. To examine what we will get in return, we need to value the health improvements that result from medicine.
I have done this in other work (Cutler, 2003) . My conclusion is that medical spending is almost certainly worth the cost. We spend more on medical care, but we get even more in return. As an example, consider treatment changes in cardiovascular disease. As noted above, the average 45 year-old is expected to live another 5 years now compared to 1950. Other work that I have done suggests that about 3 years of this improvement comes from medical advance in the treatment of coronary heart disease.
These advances are of several forms: intensive medical care that saves the lives of people having a heart attack or other acute incident (bypass surgery, angioplasty, thrombolytic drugs, beta blockers, cardiac catheterization, and so on); and medications taken on a regular basis that prevent the incidence of acute events or lessen their long-term consequences (anti-hypertensive medications, cholesterol lowering drugs, and the like).
together with public health improvements such as reduced smoking and lower fat diets, these changes have led to significant increases in longevity.
Those three years of life came at a cost, however. I estimate that the average 45 year-old today will spend $30,000 more on cardiovascular disease over his remaining life than the equivalent person would have in 1950.
Hence, the tradeoff: $30,000 of spending for an 3 additional years of life. Is it worth it? Almost any sensible value for a year of life suggests that this is a good investment. A common metric in economics is that a year of life is worth about $100,000. In present value, therefore, the 3 years of additional life from medical advances in the treatment of cardiovascular disease is worth about $120,000 per person. This is four times the additional cost. The implication of this calculation is that medical spending is not bad. It is burdensome, to be sure, but not harmful overall.
V. Summary and Implications
The central issue in medical care is not whether we can afford to spend more on medicine, or whether it is a good idea to do so, but how we should pay for it. There are three possible ways to pay for the coming medical care burden. The optimal tradeoff between them likely differs from country to country. To illustrate the issues involved, I
focus on the possibilities in the United States.
The first option is to increase revenues from people currently alive to pay for medical care in the future. Money put aside now and saved until later can significantly reduce the burden of spending down the road. The increase in funds today can be either additional taxes, or (forced) private savings; economically, they are the same.
The simulations above give some guide as to what tax increase is necessary. If the government were to pay for all of the forecast increase, government spending in the United States would rise by about 9 percent of GDP in the coming three decades. If enacted immediately, a tax increase of a few percent of GDP would be needed to cover the deficit. Such a tax increase is large, but not unheard of.
A second method is to wait until the future and then tax working generations to pay for the increased medical care burden that future elderly will incur. The simulations again show the size of the tax increase ultimately needed -9 percent of GDP. That is a hefty amount. The efficiency consequences of such a tax would be a major issue.
The third solution is to make people pay more for medical care when they use services, especially at older ages. Many elderly in the United States face no cost sharing when using services. While Medicare requires such costs, a large number of the elderly purchase supplemental insurance or have such insurance from a former employer to offset the required cost sharing (Cutler and Wise, 2003) . As a result, care at the time of use is generally costless, and like all free services is overused. Making people pay more at the time of use is a viable option, although one would need to account for the welfare loss from increased risk bearing along with the gains from reduced moral hazard. A system with appropriate cost sharing would cost less than the current one.
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